Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program
about
Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?Surgery for local and locally advanced non-small cell lung cancerThe viral etiology of AIDS-associated malignanciesTargeting glycogen metabolism in bladder cancerEpidemiology of Lung Cancer in Korea: Recent TrendsBioactive Nutrients and Nutrigenomics in Age-Related Diseases.Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence.Passive Smoking and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies.Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.Gender differences in survival and the use of primary care prior to diagnosis of three cancers: an analysis of routinely collected UK general practice data.1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance-fluorescence imaging for tracking of chemotherapeutic agents.Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.Four different malignancies in one patient: a case report.A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis.A shift from distal to proximal neoplasia in the colon: a decade of polyps and CRC in ItalyConditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.Pursuing optimal thresholds to recommend breast biopsy by quantifying the value of tomosynthesis.Unstaged cancer in the United States: a population-based study.Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage.Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer.Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.Prospective study of fruit and vegetable intake and risk of prostate cancer.Cancer survival and excess mortality estimates among adolescents and young adults in Western Australia, 1982-2004: a population-based studyIn vivo MRI of early stage mammary cancers and the normal mouse mammary glandAssociation of CD14 variant with prostate cancer in African American men.Biology of colorectal cancer.Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.Prognosis and conditional disease-free survival among patients with ovarian cancerAlpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality riskRegulation of cancer metastasis by microRNAs.An interactive tool for individualized estimation of conditional survival in rectal cancer.The utilization of oncology web-based resources in Spanish-speaking Internet users.Age-related increase in IL-17 activates pro-inflammatory signaling in prostate cells.Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer.Conditional survival among cancer patients in the United States.Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity scoreThe hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.Palliative care provision for patients with chronic obstructive pulmonary disease.
P2860
Q21261320-E6DAF70F-BCC0-482E-9E19-6982843D20E1Q24245182-27C13EC8-67C5-4EC4-8045-913A46734D53Q24685892-14D2310F-35C5-4FFF-9048-334339C14EB9Q27025144-BCE87E66-142D-4A75-8CD2-814CD0A1FD1DQ28077423-FF39F098-C111-473A-9926-BC57C8FF3F0FQ30239072-89F1D89E-7DE0-4813-92B2-1A6D8D2A6A9DQ30248287-F776403E-97FC-4885-BA9B-6A14E19D0D4DQ30250208-9C0BAAA2-4654-4946-BF98-5B5F5F0EAA56Q30448863-F6D1DED3-D9F2-48AC-937D-9C3BC31D49EEQ30836096-1167A43C-246A-484E-93A2-D117CD78673CQ31127105-5B3A8A2F-A6DC-456C-813A-823FBFEC86F3Q33481311-25EEFA58-E4EE-4137-9DBC-FFC99E1CEAAFQ33674022-4AB5E14F-F24E-48BC-9147-5A77D23272EEQ33697475-1932FE9C-E93F-4C33-A802-CEF474493055Q33756141-184DBC6D-9185-4B30-8C70-11A1A901EC2FQ33897641-58A0ED73-404F-485D-B90B-77D87EA58726Q33958483-84B143FF-0E96-4B99-BEE1-9EBDB2DBCDD3Q34026882-0E3032BE-9670-4D7A-9A86-1F148AFC7D6BQ34212950-02B7686C-B8B8-4D01-A399-35AD10C20177Q34362327-960EF345-0E10-49F5-8E90-F6E4D69AB85BQ34443694-4D2420C4-646E-4A89-9BAE-C4E2BC8F803DQ34581329-2225D667-5312-45FD-B8A6-9C1DBAE68BF5Q34584383-91267EC9-9BDA-46C9-B392-64BE889BB0DBQ34610711-F7528716-CF82-46C7-9574-9CA20F083C43Q34615903-3DE76B1B-19C4-4440-AA33-66E011AE4530Q34669618-B1D1571E-5700-4913-8897-2C5CA52A1232Q34689297-C0EA5980-1AB0-4316-9590-3A29BF8B7AA1Q34692286-7BB0CBC0-C380-4D54-AED4-0FD83E6ACED5Q34771278-8C4CCF92-199F-4732-87B6-53F58EB8BA6FQ34947326-FFB68DF3-46E9-4892-ACC1-899158B676CEQ34978755-97276336-7481-4937-9E45-43EF2136DF43Q35052860-9275491E-DC52-4A73-9711-D097F6179716Q35165402-61B721DE-8F8B-49AC-B3A0-EA150176C02FQ35209668-B666B7C0-4D37-4A06-9787-1C85EFD2DC58Q35538312-41A51A99-1CC9-4FE7-B9B7-B88903A5A53DQ35583728-0ED1AB1A-7713-4807-8C2C-EF85DD984385Q35584226-185D06B4-D64E-428E-959B-67DE0CD64BF4Q35664302-488C9AEE-AF4C-4C28-95C0-6A0095C173ADQ35746647-06787CBF-A7B4-43B4-A91D-FD869D3BE09BQ35750714-ED8668A7-4CFD-4818-BCC8-1BF1C43CEA49
P2860
Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cancer survival and incidence ...... and End Results (SEER) program
@ast
Cancer survival and incidence ...... and End Results (SEER) program
@en
Cancer survival and incidence ...... and End Results (SEER) program
@nl
type
label
Cancer survival and incidence ...... and End Results (SEER) program
@ast
Cancer survival and incidence ...... and End Results (SEER) program
@en
Cancer survival and incidence ...... and End Results (SEER) program
@nl
prefLabel
Cancer survival and incidence ...... and End Results (SEER) program
@ast
Cancer survival and incidence ...... and End Results (SEER) program
@en
Cancer survival and incidence ...... and End Results (SEER) program
@nl
P2093
P3181
P1433
P1476
Cancer survival and incidence ...... and End Results (SEER) program
@en
P2093
Benjamin F Hankey
Brenda K Edwards
Denise Riedel Lewis
Lynn A Gloeckler Ries
Marsha E Reichman
P304
P3181
P356
10.1634/THEONCOLOGIST.8-6-541
P407
P577
2003-01-01T00:00:00Z